Emeritus professor
Nephrology
Dr. Thomas A. Depner, MD
|
|
Give Review
Doctor Thomas A. Depner, MD works in the field of Nephrology. He studied medicine at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical college. Johns Hopkins University School of Medicine is ranked 3/29 in Research/PrimaryCare. Thomas Depner is also published. He has 100 publications published. The lastest publication: "Imprecision of the hemodialysis dose when measured directly from urea removal. Hemodialysis Study Group.'
Publications
- In Reply to 'Hypotension and Frequent Hemodialysis: Clarification Requested Regarding the KDOQI Hemodialysis Adequacy Guideline 2015 Update'.
- Can oral therapy reduce uremic toxins?
- Effect of frequent hemodialysis on residual Kidney function.
- Dialysate Flow Rate and Delivered Kt/Vurea for Dialyzers with Enhanced Dialysate Flow Distribution.
- Modeled Urea Distribution Volume and Mortality in the HEMO Study.
- Can rescaling dose of dialysis to body surface area in the HEMO study explain the different responses to dose in women versus men?
- Toxic fluid flux?
- Solute-solver: a web-based tool for modeling urea kinetics for a broad range of hemodialysis schedules in multiple patients.
- "Artificial" hemodialysis versus "natural" hemofiltration.
- Comparison of proposed alternative methods for rescaling dialysis dose: resting energy expenditure, high metabolic rate organ mass, liver size, and body surface area.
- Surface-area-normalized Kt/V: a method of rescaling dialysis dose to body surface area-implications for different-size patients by gender.
- Effect of change in vascular access on patient mortality in hemodialysis patients.
- Dose of dialysis: key lessons from major observational studies and clinical trials.
- Defining ASAIO.
- Kinetics of urea and beta-microglobulin during and after short hemodialysis treatments.
- Increasing dialysate flow and dialyzer mass transfer area coefficient to increase the clearance of protein-bound solutes.
- Fifty Years of the American Society for Artificial Internal Organs: growing up with artificial organs.
- Quantifying daily hemodialysis.
- Dialyzer performance in the HEMO Study: in vivo K0A and true blood flow determined from a model of cross-dialyzer urea extraction.
- Adequacy of quotidian hemodialysis.
- How will the results of the HEMO study impact dialysis practice?
- Prescribing hemodialysis: the role of gender.
- Is Kt/V Urea a Satisfactory Measure for Dosing the Newer Dialysis Regimens?
- Extended daily dialysis: A new approach to Renal replacement for acute Renal failure in the intensive care unit.
- Relationship between apparent (single-pool) and true (double-pool) urea distribution volume.
- Association of acidosis and nutritional parameters in hemodialysis patients.
- Cardiac output and central blood volume during hemodialysis: methodology.
- Imprecision of the hemodialysis dose when measured directly from urea removal. Hemodialysis Study Group.
- Lessons from the Hemodialysis (HEMO) Study: an improved measure of the actual hemodialysis dose.
- Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients.
- Effects of hemodialyzer reuse on clearances of urea and beta2-microglobulin. The Hemodialysis (HEMO) Study Group.
- In vivo measurement of hemodialyzer fiber bundle volume: theory and validation.
- Benefits of more frequent dialysis: lower TAC at the same Kt/V.
- Hemodialysis access--the role of monitoring. In-line methods.
- Albumin synthesis, catabolism and distribution in dialysis patients.
- Comparison of methods to predict equilibrated Kt/V in the HEMO Pilot Study.
- Optimizing the treatment of the dialysis patient: a painful lesson.
- Determinants of albumin concentration in hemodialysis patients.
- Implementing a continuous Renal replacement therapies program.
- Recommended clinical practices for maximizing peritoneal dialysis clearances.
- Equations for normalized protein catabolic rate based on two-point modeling of hemodialysis urea kinetics.
- Quantifying hemodialysis.
- Multicenter clinical validation of an on-line monitor of dialysis adequacy.
- Introduction: kinetic modeling.
- Hemodialysis access recirculation measured by ultrasound dilution.
- Clinical measurement of blood flow in hemodialysis access fistulae and grafts by ultrasound dilution.
- Catheter related bacterial infections mimic reactions to exogenous pyrogens during hemodialysis.
- A nomogram approach to hemodialysis urea modeling.
- Comparison of binding by concentrated peritoneal dialysate and serum.
- Assessing adequacy of hemodialysis: urea modeling.
- Amino acid losses during hemodialysis: effects of high-solute flux and parenteral nutrition in acute Renal failure.
- Techniques for prospective detection of venous stenosis.
- Mechanisms of hypoalbuminemia in hemodialysis patients.
- Impaired plasma phenytoin binding in uremia. Effect of in vitro acidification and anion-exchange resin.
- Plasma protein binding in uremia: extraction and characterization of an inhibitor.
- Peritoneal dialysis for isopropanol poisoning.
- Nephrotic syndrome secondary to lithium therapy.
- Immune complex glomerulonephritis and dermal vasculitis following intestinal bypass for morbid obesity.
- Four methods for determining albumin in azotemic sera evaluated.
- Suppression of para-aminohippurate transport in the isolated perfused Kidney by an inhibitor of protein binding in uremia.
- Inhibition of salicylate binding to normal plasma by extracts of uremic fluids.
- Suppression of tubular anion transport by an inhibitor of serum protein binding in uremia.
- Impaired binding of drugs and endogenous ligands in renal Diseases.
- Aromatic amino acid metabolites as potential protein binding inhibitors in human uremic plasma.
- Isolation and chemical identification of inhibitors of plasma ligand binding.
- Plasma hippurate in Renal failure: high-performance liquid chromatography method and clinical application.
- Severe hypokalemia associated with pseudohypoxemia in acute nonlymphocytic leukemia.
- Mesangial glomerulopathy and IgM rheumatoid factor in rheumatoid arthritis.
- Modeling urea kinetics with two vs. three BUN measurements. A critical comparison.
- Pressure effects on roller pump blood flow during hemodialysis.
- Effectiveness of low dose erythropoietin: a possible advantage of high flux hemodialysis.
- The prevalence of hepatitis C virus antibodies among hemodialysis patients.
- High venous urea concentrations in the opposite arm. A consequence of hemodialysis-induced compartment disequilibrium.
- Adequacy of hemodialysis.
- Erythrocytosis associated with diffuse parenchymal lesions of the Kidney.
- Posttraumatic Renal artery stenosis. Cure of hypertension by late revascularization.
- Pseudotumor of the Kidney: a sequel to regional glomerulonephritis.
- Immobilization Hypercalcemia: a case report and review of the literature.
- Catheter performance.
- Urea kinetics with central vein access and unused AV access.
- Daily hemodialysis efficiency: an analysis of solute kinetics.
- Uremic toxicity: urea and beyond.
- Daily dialysis in the intensive care unit.
- Extended daily dialysis vs. continuous hemodialysis for ICU patients with acute Renal failure: a two-year single center report.
- Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from the DOPPS.
- Effects of reduced intradialytic urea generation rate and residual Renal clearance on modeled urea distribution volume and Kt/V in conventional, daily, and nocturnal d...
- Standard Kt/Vurea: a method of calculation that includes effects of fluid removal and residual Kidney clearance.
- In-center hemodialysis six times per week versus three times per week.
- Effect of dialysis dose and membrane flux in maintenance hemodialysis.
- Solute clearances and fluid removal in the frequent hemodialysis network trials.
- Dosing intermittent haemodialysis in the intensive care unit patient with acute Renal failure--estimation of urea removal and evidence for the regional blood flow model.
- Hemodialysis adequacy: basic essentials and practical points for the nephrologist in training.
- The spectrum of infection-related morbidity in hospitalized haemodialysis patients.
- Design of the Dialysis Access Consortium (DAC) Aggrenox Prevention Of Access Stenosis Trial.
- Factors that affect postdialysis rebound in serum urea concentration, including the rate of dialysis: results from the HEMO Study.
- Prescribing an equilibrated intermittent hemodialysis dose in intensive care unit acute Renal failure.
- Anthropometrically estimated total body water volumes are larger than modeled urea volume in Chronic hemodialysis patients: effects of age, race, and gender.
- Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study.
- The Acute Dialysis Quality Initiative--part III: solute control (treatment dose).
Schools
Johns Hopkins University School Of Medicine
CaseWestern Reserve University Medical School Hospital
CaseWestern Reserve University Medical School Hospitals
University Of California Davis Medical Center
University Of Portland
Conditions Treated
- Calcium Metabolism Disorders
- Chronic Kidney Diseases
- End-Stage Renal Disease
- Hypercalcemia
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Education
-
University of California Davis -
Case Western Reserve University - University Hospitals -
Johns Hopkins University School of Medicine
Hospital
-
University of California, Davis Medical Center
Helpful Reviews
Similar Doctors
|
Dr. Kai-Ting Hu, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Muna A. Alnimri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Burl R. Don, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jin T. Kim, MD |
|
|
Dr. Jane Y. Yeun, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jamie L. Ross, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janet Y. Young, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mona Singh, MD |
|
|
Dr. Andrew I. Chin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elena V. Gelfand, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Muralikrishna S. Golconda, MD
This Doctor is OpenDoctor Recommended.
|